PatientsVille.com Logo

Coronary artery disease and Bystolic

PatientsVille

Coronary Artery Disease Symptoms and Causes

Coronary artery disease (CAD) is the most common type of heart disease. It is the leading cause of death in the United States in both men and women.

CAD happens when the arteries that supply blood to heart muscle become hardened and narrowed. This is due to the buildup of cholesterol and other material, called plaque, on their inner walls. This buildup is called atherosclerosis. As it grows, less blood can flow through the arteries. As a result, the heart muscle can't get the blood or oxygen it needs. This can lead to chest pain (angina) or a heart attack. Most heart attacks happen when a blood clot suddenly cuts off the hearts' blood supply, causing permanent heart damage.

Over time, CAD can also weaken the heart muscle and contribute to heart failure and arrhythmias. Heart failure means the heart can't pump blood well to the rest of the body. Arrhythmias are changes in the normal beating rhythm of the heart.

NIH: National Heart, Lung, and Blood Institute

Check out the latest treatments for coronary artery disease

coronary artery disease treatment research studies

Bystolic clinical trials, surveys and public health registries


Find Drug Side Effect reports



Bystolic Side Effects

Fatigue (99)
Dizziness (84)
Headache (75)
Dyspnoea (63)
Blood Pressure Increased (53)
Heart Rate Decreased (47)
Oedema Peripheral (46)
Insomnia (46)
Nausea (42)
Asthenia (39)
Chest Pain (36)
Bradycardia (34)
Diarrhoea (34)
Rash (31)
Pruritus (29)
Alopecia (29)
Pain In Extremity (27)
Paraesthesia (25)
Chest Discomfort (21)
Arthralgia (20)
Palpitations (19)
Hypotension (19)
Abdominal Pain Upper (19)
Depression (18)
Fall (18)
Weight Increased (18)
Vision Blurred (17)
Abdominal Distension (17)
Hypertension (16)
Cough (16)
Abnormal Dreams (15)
Abdominal Discomfort (15)
Heart Rate Increased (15)
Pain (15)
Hypoaesthesia (15)
Muscle Spasms (15)
Blood Glucose Increased (14)
Joint Swelling (14)
Myalgia (14)
Migraine (13)
Erythema (13)
Anxiety (13)
Convulsion (12)
Hyperhidrosis (12)
Unevaluable Event (12)
Tremor (12)
Weight Decreased (12)
Heart Rate Irregular (11)
Vomiting (11)
Malaise (11)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

Started taking Bystolic 5mg on Thursday for tachycardia. Sunday, had blurred vision. (Was driving and it was so bad that the interstate signs were blurred!) Stopped medicine and called doctor on Monday. Tuesday, called back because nobody saw f

Ok,So My Doctor just gave Bystlic to me I was on a different one and now this Im so so afriad to take this im only 33 yrs old and the blood pressure meds Im on it not lowering it enought..... I guess I will not take this med..</span>

<strong>I have been taking Bystolic for about a month, my right leg has been 'killing' me ever since, I have alot of knee pain, and constant cramps in my right calf. The pain just seems to travel up and down my leg,can this be caused by Bystoli

<strong>I took Bystolic 5 mg for 3 days. Immediately started feeling bad.Heartrate is still 117 to 125, and blood pressure went up.It is 168/125.He gave me Bumex 1 mg with this. I take the KLOR 40 potasium with it. I am quiting both. Can not sl

64 years old. Good health, high BP extreme tension stress from work. Started lisinopril didn't lower BP, changed to Bystolic 10mg, lowered BP quickly, Constantly tired feeling, vey dizzy mostly in the morning constant coughing up mucus, lungs clear

8-) 8-) 8-)

About a month ago I had a dr. appt and my blood pressure was a little elevated although I am taking 300mg of cartia xt and hctz 37.5/triam25mg.My M.D.,thought that I should also take 10mg of bystolic, about 3 to 4 weeks into takin

After two week my chest got tight. Couldn't breath right. And my back by my shoulder blade hurt. I was on 5 mg. I'm going to try some natural ways celery magnesium garlic.

Bystolic caused weight gain and gout

Bystolic has dropped my bp but my pulse still remains pretty fast.

A flu epidemic at a boarding school would be a concern for the Centers for Disease Control true or false?

Why do doctors keep the availabilty of the test for DPD deficiency a secret??? My sister is a doctor, infectious disease, at St Francis in Charleston, SC. Our father was treated by an oncologist well known to my sister, a 'colleague' you might s

I am having cramps, muscle pain, memory loss, I have been on Revlmid for about 1 year. Does anybody else my age have this disease, I am only 46 yr woman.

<b><span style=' padding: 0px; margin: 0px;'>Hi Can any1 tell me why this medicine (Betaserc) people use and if the disease is dangerous....plz tell me on urgent basis...any1 thnx</b>

<strong>I have very high blood pressure, was put on this drug approximately 5 weeks ago. I was on Coozar previous to this. I also take paracetamol x 1 bd, ceres x 1, venlafaxine x 1, omeprazole x 1, aspirin x 1, have Charcot Marie Tooth Disease

<strong>Male</strong> <strong>42yold</strong> <strong>Zarator use since Oct2008</strong> <strong>Heart strok in Oct2008, 2 stents on left artery (HSM, Lisbon)</strong> <strong></strong>

54y/o, WM, Status post quadruple coronary artery bypass graft surgery(10 months ago). Surgery went well, only complication was a pretty large left pleural effusion requiring chest tube placement. Resolved well, no further problems

55 yo dx with osearthritis and degenative disc disease, prescribed Mobic 15 mg once a day on medication for past year with no problem.For the past 6weeks had gradual onset of facial and extremity edema , esophageal spasm and expir

After becoming very ill, suffering much pain, losing weight and having many sleepless nights i was finally diagnosed with hoshimotos disease, subsequently i have hypothyroidism. I am only talking 50 mg oroxine 3 times a week and 100 mg the other 2 d

As with any drug, you must weigh the benefits vs. the risks. Revlimid is an incredible drug, which controls my myeloplastic disease with deletion 5q

Coronary Artery Disease Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Comparative Effects of Nebivolol and Metoprolol on Femal Sexual Function
Conditions: Hypertension;   Female Sexual Dysfunction
Interventions: Drug: nebivolol and metoprolol succinate;   Drug: metoprolol succinate and nebivolol
Outcome Measures: Change in FSF and CSFQ, two validated questionnaires for assessment of sexual function.;   The effects of nebivolol and metoprolol on sexual function and to compare the effects of both drugs on vitality, work and life performance, and work and life satisfaction.
2 Unknown  Comparative Effects of Nebivolol Versus Placebo on Sodium Sensitivity of Blood Pressure in Hispanic Postmenopausal Women With Hypertension
Condition: Hypertension
Interventions: Drug: nebivolol;   Drug: Nebivolol
Outcome Measures: Change and percentage change in systolic, diastolic and mean blood pressure by ABPM from final day of low sodium to the final day of high sodium in nebivolol versus placebo;   Differences in renal sodium excretion in response to an acute sodium load during treatment with either nebivolol or placebo.
3 Recruiting Effects of Nebivolol on Skeletal Muscle During Exercise in Hypertensive Patients
Condition: Hypertension
Interventions: Drug: Metoprolol succinate;   Drug: Nebivolol;   Drug: Hydrochlorothiazide;   Drug: DEFINITY®;   Procedure: Non-invasive measurement of Cardiac Output (CO);   Procedure: Flow mediated vasodilation;   Procedure: Endothelial cell collection;   Procedure: Microvascular perfusion assessment using Definity
Outcome Measures: Endothelial cell protein expression;   Microvascular blood flow;   Flow mediated dilation (FMD)
4 Unknown  Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients
Condition: Marfan Syndrome
Interventions: Drug: Losartan and nebivolol;   Drug: Losartan;   Drug: Nebivolol
Outcome Measures: BSA and age-adjusted aortic root diameter (sinuses of Valsalva);   The pharmacokinetics of the two drugs by age and dosages;   Comparative evaluation of the serum levels of total and active TGFb;   Quantitative assessment of the expression of the mutated gene (FBN1, both 5' and 3');   Pharmacogenetic bases of drug responsiveness (Losartan: CYP2C9 gene) (Nebivolol: CYP2D6 gene);   Aortic valve regurgitation severity;   Left ventricular end-diastolic diameter;   Left ventricular ejection fraction;   Spirometric lung volumes and flows;   QoL evaluation basing on SF-36 questionnaire;   Arterial stiffness (carotids)
5 Recruiting Nebivolol Effects on Endothelial Function and Erectile Function
Condition: Erectile Dysfunction
Interventions: Drug: Nebivolol;   Drug: Sugar Pill
Outcome Measures: Primary objective is to determine if treatment with nebivolol improves endothelial function and erectile function in men with pre-hypertension and stage 1 hypertension. This will be assessed by change in IIEF-5 at baseline, 2 and 3 months;   Change in Endopat score;   Change in SphygmoCor results;   Change in SQOLM score
6 Recruiting Study to Evaluate Effect of Nebivolol on Angina in Women With Microvascular Disease
Condition: Microvascular Angina
Intervention: Drug: Nebivolol
Outcome Measures: Seattle Angina Questionnaire Score;   peak VO2 measured by cardiopulmonary exercise testing;   resource utilization questionnaire;   SF36
7 Recruiting Comparative Study of the Effects of Telmisartan and Nebivolol
Condition: Hypertension
Interventions: Drug: TELMISARTAN;   Drug: NEBIVOLOL
Outcome Measures: Change from baseline in 24h blood pressure;   Change from baseline in arterial stiffness
8 Unknown  Regression of Myocardial Steatosis by Nebivolol
Condition: Cardiac Steatosis and Lipotoxicity
Intervention: Drug: Nebivolol
Outcome Measures: Myocardial triglyceride content;   Cardiac function;   Regression of concentric cardiac remodeling;   Regression of steatosis in other non-adipocyte tissue;   Regression of subcutaneous fat
9 Unknown  Nebivolol and Endothelial Regulation of Fibrinolysis (NERF)
Conditions: Prehypertension;   Hypertension
Interventions: Drug: Nebivolol;   Drug: Metoprolol;   Drug: Placebo
Outcome Measure: Changes from baseline in endothelial t-PA release
10 Recruiting A Study Examining the Effects of Nebivolol Compared to Atenolol on Endothelial Function
Condition: Hypertension
Interventions: Drug: Nebivolol;   Drug: atenolol;   Drug: placebo
Outcome Measures: Comparing effects of nebivolol against atenolol and placebo on endothelial function;   Evaluate effects of nebivolol as compared to atenolol and placebo
11 Recruiting Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy
Conditions: Duchenne Muscular Dystrophy;   Cardiomyopathy;   Heart Failure
Interventions: Drug: Nebivolol;   Drug: Placebo
Outcome Measures: Left ventricular systolic dysfunction;   Right ventricular ejection fraction;   NT-ProBNP;   Left ventricular dysfunction;   Hospitalizations;   Mortality
12 Not yet recruiting CPAP and Nebivolol in Hypertensive Obstructive Sleep Apnea (OSA) Patients.
Conditions: Hypertension;   Endothelial Dysfunction;   Obstructive Sleep Apnea
Interventions: Drug: Nebivolol;   Device: Continuous positive airway pressure (CPAP)
Outcome Measures: change in mean arterial blood pressure;   change in endothelial function
13 Unknown  Nebivolol and the Endothelin (ET)-1 System
Conditions: Prehypertension;   Hypertension
Interventions: Drug: Nebivolol;   Drug: Metoprolol;   Drug: Placebo
Outcome Measure: ET-1-mediated vasoconstrictor tone
14 Recruiting Comparison of 2 Beta Blocker Drugs on Peripheral Arterial Disease in Patients With High Blood Pressure
Conditions: Peripheral Artery Disease;   Hypertension
Interventions: Drug: nebivolol;   Drug: Metoprolol succinate
Outcome Measures: Peak Walking Time;   Walking Impairment Questionnaire;   Ankle-brachial index;   markers of inflammation.;   Claudication Onset Time
15 Recruiting Effect of Nebivolol on the Blood Flow in Hearts of Adults With High Blood Pressure and Abnormal Filling of Heart
Conditions: Hypertension;   Left Ventricular Diastolic Dysfunction
Intervention: Drug: Nebivolol
Outcome Measures: Improvement in exercise tolerance;   E velocity indexed to e' (E/e' ratio) of the left ventricle;   Untwist rate of the left ventricle
16 Recruiting Safety Study of Nebivolol for COPD Patients
Condition: High Blood Pressure
Interventions: Drug: Placebo;   Drug: Nebivolol
Outcome Measures: to assess blood pressure control;   to assess pulmonary function tests
17 Unknown  Influence of Nebivolol on Postmenopausal Women
Conditions: Hot Flashes;   Heart Rate;   Blood Pressure;   Endostatin;   Sexual Function
Intervention:
Outcome Measures: Number of hot flashes/palpitations;   Hemodynamic changes;   Sexual function;   Endostatin;   Quality of life
18 Recruiting Nebivolol Versus Sustained Release Metoprolol Succinate in Patients With Chronic Kidney Disease
Condition: Chronic Kidney Disease
Intervention:
Outcome Measures: Primary Efficacy;   Secondary Efficacy
19 Recruiting Improving Treatment Personalization of Pulmonary Hypertension Associated With Diastolic Heart Failure
Conditions: Pulmonary Hypertension;   Diastolic Heart Failure;   Heart Failure With Preserved Ejection Fraction
Intervention: Drug: Nebivolol
Outcome Measures: Changes in pulmonary vascular pressure;   Changes in 6-minute walk distance
20 Recruiting Treatment of Supine Hypertension in Autonomic Failure
Condition: Hypertension
Interventions: Drug: Clonidine;   Drug: Nitroglycerin transdermal;   Drug: Dipyridamole/ Aspirin (Aggrenox);   Drug: Desmopressin (DDAVP);   Drug: Sildenafil;   Drug: Nifedipine;   Drug: Hydralazine;   Drug: Hydrochlorothiazide;   Drug: Placebo;   Drug: Bosentan;   Drug: Diltiazem;   Drug: Eplerenone;   Drug: guanfacine;   Dietary Supplement: L-arginine;   Drug: captopril;   Drug: carbidopa;   Drug: losartan;   Drug: metoprolol tartrate;   Drug: nebivolol hydrochloride;   Drug: prazosin hydrochloride;   Drug: tamsulosin hydrochloride;   Other: Head-up tilt.;   Drug: aliskiren;   Other: Local heat stress
Outcome Measures: Decrease in supine systolic blood pressure;   Decrease in pressure natriuresis